Research Paper Volume 15, Issue 12 pp 5304—5338
Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma
Figure 5. Further validation of model effects. Survival curves of patients in different clinical states (A–F).